Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Insufficiency,Type 2 Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02827708
What this trial is testing

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 324
Not applicableStudy completedNCT04417725
What this trial is testing

Burden of Chronic Kidney Disease (CKD), Type 2 Diabetes Mellitus (T2DM), and Comorbid T2DM/CKD in Alberta, Canada

Who this might be right for
Chronic Kidney DiseasesType 2 Diabetes
Medlior Health Outcomes Research Ltd 588,170
Not applicableStudy completedNCT04549324
What this trial is testing

Sleep Apnea, Coronary Atherosclerosis and Heart Failure in Diabetes Patients With Nephropathy

Who this might be right for
Sleep ApneaDiabetic Nephropathy Type 2Coronary Atheroscleroses+4 more
University of Aarhus 74
Not applicableStudy completedNCT03077386
What this trial is testing

Enhancing Community Health Through Patient Navigation, Advocacy and Social Support

Who this might be right for
HypertensionDiabetes Mellitus, Type 2Chronic Kidney Diseases+4 more
University of Calgary 176
Not applicableStudy completedNCT04790604
What this trial is testing

ENCOMPASS: Expansion Study A, RCT

Who this might be right for
HypertensionDiabetes Mellitus, Type 2Chronic Kidney Diseases+4 more
University of Calgary 96
Not applicableEnded earlyNCT02524938
What this trial is testing

Dietary Polyphenols and Glycation in Renal Insufficiency

Who this might be right for
Diabetes Mellitus, Type 2Renal Insufficiency, Chronic
NHS Greater Glasgow and Clyde 9
Large-scale testing (Phase 3)Study completedNCT02413398
What this trial is testing

Evaluate the Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 321
Not applicableLooking for participantsNCT07554469
What this trial is testing

An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CKD) Linked to Type 2 Diabetes, by Looking at Changes in a CKD Risk Score

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Bayer 500
Post-approval studies (Phase 4)Study completedNCT06252051
What this trial is testing

Effectiveness of Trivalent Influenza Vaccine (TIV) in Type 2 Diabetes Mellitus (T2DM) Patients With and Without Complications of Chronic Kidney Disease (CKD)

Who this might be right for
InfluenzaVaccine ReactionDiabetes Mellitus+1 more
Universitas Padjadjaran 76
Post-approval studies (Phase 4)Study completedNCT01394341
What this trial is testing

Liraglutide Treatment to Patients With Severe Renal Insufficiency

Who this might be right for
Type 2 Diabetes MellitusEnd-stage Renal Disease
Bo Feldt-Rasmussen 40
Testing effectiveness (Phase 2)Study completedNCT04595370
What this trial is testing

Efficacy, Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney Disease

Who this might be right for
Heart FailureChronic Kidney Disease
AstraZeneca 153
Early research (Phase 1)Ended earlyNCT01549769
What this trial is testing

Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes

Who this might be right for
Renal Insufficiency, ChronicDiabetes Mellitus, Type 2
Biogen 24
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Large-scale testing (Phase 3)Study completedNCT00663260
What this trial is testing

Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 631
Testing effectiveness (Phase 2)Study completedNCT02836574
What this trial is testing

Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease
Prokidney 83
Not applicableLooking for participantsNCT07485075
What this trial is testing

Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial

Who this might be right for
Diabetes Type 2Kidney Disease
Steno Diabetes Center Copenhagen 104
Early research (Phase 1)Study completedNCT06246175
What this trial is testing

HRS9531 in Participants With Impaired Kidney Function and Healthy Subjects

Who this might be right for
Type 2 Diabetes
Fujian Shengdi Pharmaceutical Co., Ltd. 32
Testing effectiveness (Phase 2)Study completedNCT05216172
What this trial is testing

AZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNce

Who this might be right for
Type 2 DiabetesDiabetes Mellitus, Type 2Renal Transplant+2 more
Queen Mary University of London 26
Not applicableUnknownNCT02844153
What this trial is testing

Metformin Use in Chronic Kidney Disease: The CKD-Met Study

Who this might be right for
Type 2 DiabetesChronic Kidney Disease
Hospices Civils de Lyon 1,000
Early research (Phase 1)Study completedNCT01907113
What this trial is testing

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BI 10773 in Type II Diabetes Patients With Different Degrees of Renal Impairment

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 40
Next Page